Literature DB >> 35813544

Osteoarthritis Can Also Start in the Gut: The Gut-Joint Axis.

Brendan Gleason1, Emanuele Chisari1,2, Javad Parvizi1.   

Abstract

Background: Osteoarthritis is a common cause of pain and disability with an increasing prevalence among the global population (Hunter and Bierma-Zeinstra in Lancet 393(10182):1745-1759, 2019; Zhang and Jordan in Clinics in Geriatric Medicine 26(3):355-369, 2010). Altered immune responses and low-grade systemic inflammation driven by gut dysbiosis are being increasingly recognized as contributing factors to the pathophysiology of OA (Tan et al. in International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185X.14123, 2021; Binvignat et al. in Joint, Bone, Spine 88(5):105203, 2021; Ramasamy et al. in Nutrients 13(4):1272, 2021), which increased the interest in the so-called "gut-joint axis". The various microbiota in the gastrointestinal tract is commonly referred to as the gut microbiome. The gut microbiome is affected by age, sex, and immune system activity as well as medications, environment, and diet (Arumugam in Nature. https://doi.org/10.1038/nature09944, 2011). The microbiome is pivotal to maintain host health and contributes to nutrition, host defense, and immune development (Nishida et al. in Clinical Journal of Gastroenterology 11:1-10, 2018). Alterations in this microbiome can induce dysbiosis, which is associated with many human disease states including allergies, autoimmune disease, diabetes, and cancer (Lin and Zhang in BMC Immunology 18(1):2, 2017). A gut-joint axis is proposed as a link involving the gastrointestinal microbiome, the immune response that it induces, and joint health.
Results: Emerging evidence has shown that there are specific changes in the microbiome that are associated with osteoarthritis, including increased Firmicutes/Bacteroides ratio, Streptococcus spp. prevalence, and local inflammation (Collins in Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2015.03.014, 2015; Rios in Science and Reports. https://doi.org/10.1038/s41598-019-40601-x, 2019; Schott in JCI insight. https://doi.org/10.1172/jci.insight.95997, 2018; Boer et al. in Nature Communications 10:4881, 2019). Both the innate and adaptive immune systems are affected by the gut microbiome and can become dysregulated in dysbiosis which ultimately triggers events associated with joint OA. Conclusions: The gut is an intriguing and novel target for OA therapy. Dietary modification or supplementation with fiber, probiotics, or prebiotics could provide a positive impact on the gut joint axis. © Indian Orthopaedics Association 2022.

Entities:  

Keywords:  Diet; Dysbiosis; Gut–joint axis; Immune response; Inflammation; Joint; Microbiome; Obesity; Osteoarthritis

Year:  2022        PMID: 35813544      PMCID: PMC9232669          DOI: 10.1007/s43465-021-00473-8

Source DB:  PubMed          Journal:  Indian J Orthop        ISSN: 0019-5413            Impact factor:   1.033


  63 in total

1.  Structural variation in the gut microbiome associates with host health.

Authors:  David Zeevi; Tal Korem; Anastasia Godneva; Noam Bar; Alexander Kurilshikov; Maya Lotan-Pompan; Adina Weinberger; Jingyuan Fu; Cisca Wijmenga; Alexandra Zhernakova; Eran Segal
Journal:  Nature       Date:  2019-03-27       Impact factor: 49.962

Review 2.  Epidemiology of osteoarthritis.

Authors:  Yuqing Zhang; Joanne M Jordan
Journal:  Clin Geriatr Med       Date:  2010-08       Impact factor: 3.076

Review 3.  Review: Metabolic Regulation of Inflammation in Osteoarthritis.

Authors:  Francis Berenbaum; Timothy M Griffin; Ru Liu-Bryan
Journal:  Arthritis Rheumatol       Date:  2017-01       Impact factor: 10.995

4.  Induction of intestinal Th17 cells by segmented filamentous bacteria.

Authors:  Ivaylo I Ivanov; Koji Atarashi; Nicolas Manel; Eoin L Brodie; Tatsuichiro Shima; Ulas Karaoz; Dongguang Wei; Katherine C Goldfarb; Clark A Santee; Susan V Lynch; Takeshi Tanoue; Akemi Imaoka; Kikuji Itoh; Kiyoshi Takeda; Yoshinori Umesaki; Kenya Honda; Dan R Littman
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

5.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection.

Authors:  Melissa A Kinnebrew; Carles Ubeda; Lauren A Zenewicz; Nichole Smith; Richard A Flavell; Eric G Pamer
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

7.  Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits.

Authors:  Katharina Brandl; George Plitas; Coralia N Mihu; Carles Ubeda; Ting Jia; Martin Fleisher; Bernd Schnabl; Ronald P DeMatteo; Eric G Pamer
Journal:  Nature       Date:  2008-08-24       Impact factor: 49.962

8.  High-fat diet accelerates progression of osteoarthritis after meniscal/ligamentous injury.

Authors:  Robert A Mooney; Erik R Sampson; Jaclyn Lerea; Randy N Rosier; Michael J Zuscik
Journal:  Arthritis Res Ther       Date:  2011-12-07       Impact factor: 5.156

9.  Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity.

Authors:  Thomas B Clarke; Kimberly M Davis; Elena S Lysenko; Alice Y Zhou; Yimin Yu; Jeffrey N Weiser
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

10.  Intestinal microbiome composition and its relation to joint pain and inflammation.

Authors:  Cindy G Boer; Djawad Radjabzadeh; Carolina Medina-Gomez; Sanzhima Garmaeva; Dieuwke Schiphof; Pascal Arp; Thomas Koet; Alexander Kurilshikov; Jingyuan Fu; M Arfan Ikram; Sita Bierma-Zeinstra; André G Uitterlinden; Robert Kraaij; Alexandra Zhernakova; Joyce B J van Meurs
Journal:  Nat Commun       Date:  2019-10-25       Impact factor: 14.919

View more
  1 in total

Review 1.  The effects and significance of gut microbiota and its metabolites on the regulation of osteoarthritis: Close coordination of gut-bone axis.

Authors:  Lei Liu; Feng Tian; Guo-Yuan Li; Wei Xu; Rui Xia
Journal:  Front Nutr       Date:  2022-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.